ASAN vs BBAI

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and no available Altman Z-Score, limiting distress risk assessment. Despite strong gross margins and accelerating revenue and earnings growth, the company remains deeply unprofitable with negative ROE and ROA, high valuation multiples, and deteriorating insider sentiment. Aggressive insider selling, a bearish technical trend, and a significant disconnect between current price and analyst target further weigh on the outlook. While earnings surprises have been consistently positive, the overall risk profile remains elevated in a high-valuation, low-profitability context.

The Advanced Deterministic Scorecard shows a Piotroski F-Score of 6/9, indicating stable financial health, but the absence of an Altman Z-Score and negative profitability metrics raise concerns. Despite strong liquidity (Current Ratio: 3.13), the company is deeply unprofitable with a -295.61% profit margin and -120.34% ROE, while revenue is declining YoY by -20.10%. Valuation multiples are extremely stretched with a Price/Sales of 18.48 and a negative Forward P/E of -29.10, suggesting speculative pricing unsupported by fundamentals. Insider selling and weak earnings surprise history further undermine confidence.